ascendis pharma glp-1 receptor agonist Schematic illustration of monoagonists, dual agonists and triple Current Insights, Advantages and Challenges
Description
As 2025 gets underway, we take a look at what lies ahead for the highly dynamic market for effective anti-obesity medications (AOMs)
Promotes a healthy blood sugar response*: Reducose slows down the breakdown of carbs to reduce post-meal glucose spikes by up to 40%, while Feiolix supports insulin sensitivity and glucose metabolism.
The new class of weight-loss medications are hailed as game-changing wonder drugs, but just how safe and effective are they
Understand causes, benefits, and practical insights to support better health and informed decisions.
Both human and animal studies reported inconsistent BP response to acute administration but showed hypotensive effect of chronic administration of GLP-1/ GLP-1 RAs
Learn about GLP-1 agonists, what they can help treat, and how they work to promote weight loss
